Tufts Health Together (MassHealth) · Zepbound and Wegovy coverage

Does Tufts Health Together (MassHealth) cover Zepbound or Wegovy?

Last updated

Wegovy is its sole preferred GLP-1 since July 2026; MassHealth ended weight-loss coverage.

If it is not covered: the lowest cash prices now

  • F

    Without insurance: compounded tirzepatide on a monthly plan, not FDA-approved

    FlatRx

    $118/mo · $118 a month

  • Compounded tirzepatide, not FDA-approved: at a seller we link to

    Eden

    $129/mo · about $12 more per 30 days than FlatRx

  • Compounded semaglutide, not FDA-approved: at a seller we link to

    Eden

    $99/mo · about $22 more per 30 days than Sunlight

  • Without insurance: compounded semaglutide on a monthly plan, not FDA-approved

    Sunlight

    $78/mo · about $84 per 30 days

Wegovy is its sole preferred GLP-1 since July 2026; MassHealth ended weight-loss coverage. Point32Health says Tufts Health Together made Wegovy its sole preferred drug for all medically accepted uses from July 1, 2026, and Zepbound is no longer preferred. In its words: "For Tufts Health Together, effective for dates of service beginning July 1, 2026, Zepbound will no longer be considered a preferred drug; Wegovy will be the sole preferred drug for all medically accepted indications." (Point32Health, MassHealth coverage change: anti-obesity medications (June 2026), point32health.org, read Nov 20, 2026).

Questions

Tufts Health Together (MassHealth), Zepbound and Wegovy: common questions

Does Tufts Health Together (MassHealth) cover Zepbound for weight loss?

Wegovy is its sole preferred GLP-1 since July 2026; MassHealth ended weight-loss coverage. Point32Health says Tufts Health Together made Wegovy its sole preferred drug for all medically accepted uses from July 1, 2026, and Zepbound is no longer preferred. In its words: "For Tufts Health Together, effective for dates of service beginning July 1, 2026, Zepbound will no longer be considered a preferred drug; Wegovy will be the sole preferred drug for all medically accepted indications." (Point32Health, MassHealth coverage change: anti-obesity medications (June 2026), point32health.org, read Nov 20, 2026). Zepbound not covered: the cash price at your dose

Does Tufts Health Together (MassHealth) cover Wegovy for weight loss?

Wegovy is its sole preferred GLP-1 since July 2026; MassHealth ended weight-loss coverage. Point32Health says Tufts Health Together made Wegovy its sole preferred drug for all medically accepted uses from July 1, 2026, and Zepbound is no longer preferred. In its words: "For Tufts Health Together, effective for dates of service beginning July 1, 2026, Zepbound will no longer be considered a preferred drug; Wegovy will be the sole preferred drug for all medically accepted indications." (Point32Health, MassHealth coverage change: anti-obesity medications (June 2026), point32health.org, read Nov 20, 2026). Wegovy not covered: the cash price at your dose

Does Massachusetts Medicaid cover Wegovy or Zepbound for weight loss?

No. MassHealth (Massachusetts Medicaid) stopped covering Wegovy and Zepbound for weight loss alone on Jul 3, 2026. The state's notice: "Effective July 3, 2026, the drugs listed below in Table 1 will no longer be covered for MassHealth members when used only for the treatment of obesity or overweight." Its Table 1 lists Saxenda (liraglutide), Wegovy (semaglutide) and Zepbound (tirzepatide), for members in fee for service and in managed care alike. (MassHealth Pharmacy Facts 276 (corrected), mass.gov/doc/pharmacy-facts-276-may-13-2026-corrected-0/download, read Nov 17, 2026). Every program must still cover some uses: in KFF's words, "coverage of GLP-1 drugs for the treatment of obesity remains optional for states, while coverage is required for drugs approved for the treatment of diabetes and, since March 2024 and December 2024, for the treatment of cardiovascular disease (Wegovy) and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound), respectively" (KFF, Medicaid Coverage of and Spending on GLP-1s (January 2026), kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s, read Nov 17, 2026). Massachusetts Medicaid and GLP-1s: the state's words, and the cash price

Is Tufts Health Together (MassHealth) dropping GLP-1 coverage for weight loss?

Wegovy is its sole preferred GLP-1 since July 2026; MassHealth ended weight-loss coverage. Point32Health says Tufts Health Together made Wegovy its sole preferred drug for all medically accepted uses from July 1, 2026, and Zepbound is no longer preferred. In its words: "For Tufts Health Together, effective for dates of service beginning July 1, 2026, Zepbound will no longer be considered a preferred drug; Wegovy will be the sole preferred drug for all medically accepted indications." (Point32Health, MassHealth coverage change: anti-obesity medications (June 2026), point32health.org, read Nov 20, 2026).

What do Zepbound and Wegovy cost if Tufts Health Together (MassHealth) does not cover them?

Zepbound costs $299/28 days at 2.5 mg and $449/28 days at 15 mg without insurance at Amazon Pharmacy and LillyDirect (Eli Lilly), checked Nov 19, 2026 on pharmacy.amazon.com and zepbound.lilly.com. At 15 mg, the terms: at Amazon Pharmacy, through Dec 31, 2026, with Lilly's self-pay card, whose terms on Lilly's Zepbound savings page say "Card expires and savings end on 12/31/2026" and require each refill within 45 days of the previous delivery, or Lilly's regular $699 applies; at LillyDirect (Eli Lilly), Self Pay Journey price with a refill within 45 days; otherwise $499 at 7.5 mg or $699 at 10 to 15 mg. Wegovy costs $199/28 days, through Dec 31, 2026 at 0.25 mg and $349/28 days at 2.4 mg without insurance at Amazon Pharmacy and NovoCare (Novo Nordisk), checked on pharmacy.amazon.com Nov 19, 2026 and on novocare.com Nov 11, 2026. Compounded, not FDA-approved: compounded tirzepatide from $118/mo at FlatRx ($118 a month) among sellers that serve Massachusetts; compounded semaglutide from $78/mo at Sunlight (about $84 per 30 days) among sellers that serve Massachusetts. Every GLP-1's cash price without insurance

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

What a plan covers is decided by the plan and the employer or program behind it, and changes; check your own plan's drug list before you rely on this. This page reports the insurer's own published words and sellers' own prices, not insurance or medical advice. Compounded medications are not FDA-approved. GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.